May 2nd, 2022 (Earnings Report) Dear Reader, We just identified several healthtech stocks that are expected to release earnings this week. If you are interested in any of these companies, we encourage you to do your own research and due diligence before pursuing any investments. Keep in mind, the actual earnings date and time may change, so if you’re interested in any of these companies you will need to pay close attention to their announcements.
Addus Homecare
Symbol: ADUS
Recent Price: $$85.10
Average Analyst Price Target: $120.00 (41.01%)
Market Cap: $$1.37B
Last Year's EPS: $0.74
Consensus EPS Forecast: $0.75
Expected Earnings Date: May 01 2022
Recent Analyst Action: Joanna Gajuk, analyst at Bank of America Securities, reiterates coverage on Addus Homecare (ADUS) in the Healthcare sector with a Buy rating and a price target of $ 110 (2 weeks ago).
TipRanks.com also reports that Addus Homecare currently has 3 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $120.00 . The target pricing ranges from a high forecast of $125.00 down to a low forecast of $110.00. Addus Homecare (ADUS)’s last closing price was $$85.10 which would put the average price target at 41.01% upside.Here are 3rd party ratings for ADUS:
- TipRanks.com: Strong Buy
- TradingView.com: Neutral
- Yahoo! Finance: Bearish Short-Term Outlook
- Barchart.com: Weak sell
- Zacks.com: Sell, Bottom 17% (211 out of 253)
--------------------------------------------------------------------------
InMode
Symbol: INMD
Recent Price: $$25.51
Average Analyst Price Target: $84.67 (231.91%)
Market Cap: $$2.12B
Last Year's EPS: $0.35
Consensus EPS Forecast: $0.36
Expected Earnings Date: May 01 2022
Recent Analyst Action: Michael Matson, analyst at Needham, reiterates coverage on InMode (INMD) in the Healthcare sector with a Buy rating and a price target of $ 82 (2 weeks ago).
TipRanks.com also reports that InMode currently has 3 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $84.67 . The target pricing ranges from a high forecast of $90.00 down to a low forecast of $82.00. InMode (INMD)’s last closing price was $$25.51 which would put the average price target at 231.91% upside.Here are 3rd party ratings for INMD:
- TipRanks.com: Strong Buy
- TradingView.com: Sell
- Yahoo! Finance: Bullish Short-Term Outlook
- Barchart.com: Strong sell
- Zacks.com: n/a, n/a
--------------------------------------------------------------------------
Precision BioSciences
Symbol: DTIL
Recent Price: $$2.13
Average Analyst Price Target: $12.40 (482.16%)
Market Cap: $$130.01M
Last Year's EPS: -$0.33
Consensus EPS Forecast: -$0.55
Expected Earnings Date: May 01 2022
Recent Analyst Action: Soumit Roy, analyst at JonesTrading, reiterates coverage on Precision BioSciences (DTIL) in the Healthcare sector with a Buy rating and a price target of $ 15 (3 weeks ago).
TipRanks.com also reports that Precision BioSciences currently has 5 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $12.40 . The target pricing ranges from a high forecast of $20.00 down to a low forecast of $5.00. Precision BioSciences (DTIL)’s last closing price was $$2.13 which would put the average price target at 482.16% upside.Here are 3rd party ratings for DTIL:
- TipRanks.com: Strong Buy
- TradingView.com: Sell
- Yahoo! Finance: Bullish Short-Term Outlook
- Barchart.com: Strong sell
- Zacks.com: Hold, Bottom 40% (152 out of 253)
--------------------------------------------------------------------------
Tactile Systems Technology
Symbol: TCMD
Recent Price: $$17.55
Average Analyst Price Target: $30.67 (74.76%)
Market Cap: $$349.71M
Last Year's EPS: -$0.12
Consensus EPS Forecast: -$0.28
Expected Earnings Date: May 01 2022
Recent Analyst Action: Adam Maeder, analyst at Piper Sandler, reiterates coverage on Tactile Systems Technology (TCMD) in the Healthcare sector with a Buy rating and a price target of $ 28 (2 months ago).
TipRanks.com also reports that Tactile Systems Technology currently has 3 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $30.67 . The target pricing ranges from a high forecast of $35.00 down to a low forecast of $28.00. Tactile Systems Technology (TCMD)’s last closing price was $$17.55 which would put the average price target at 74.76% upside.Here are 3rd party ratings for TCMD:
- TipRanks.com: Strong Buy
- TradingView.com: Sell
- Yahoo! Finance: Bearish Short-Term Outlook
- Barchart.com: sell
- Zacks.com: Hold, Bottom 32% (173 out of 253)
--------------------------------------------------------------------------
uniQure
Symbol: QURE
Recent Price: $$15.81
Average Analyst Price Target: $59.67 (277.42%)
Market Cap: $$734.48M
Last Year's EPS: -$0.91
Consensus EPS Forecast: -$0.93
Expected Earnings Date: May 01 2022
Recent Analyst Action: Robyn Karnauskas, analyst at Truist Financial, reiterates coverage on uniQure (QURE) in the Healthcare sector with a Buy rating and a price target of $ 51 (2 weeks ago).
TipRanks.com also reports that uniQure currently has 10 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $59.67 . The target pricing ranges from a high forecast of $90.00 down to a low forecast of $40.00. uniQure (QURE)’s last closing price was $$15.81 which would put the average price target at 277.42% upside.Here are 3rd party ratings for QURE:
- TipRanks.com: Strong Buy
- TradingView.com: Sell
- Yahoo! Finance: Bullish Short-Term Outlook
- Barchart.com: Strong sell
- Zacks.com: Hold, Bottom 40% (152 out of 253)
--------------------------------------------------------------------------
To Your Financial Future,
The Editor, HealthTechMovers.com